Next Article in Journal
Fatty Acid Allosteric Regulation of C-H Activation in Plant and Animal Lipoxygenases
Next Article in Special Issue
Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning
Previous Article in Journal
Ab Initio Molecular Dynamics Study of Methanol-Water Mixtures under External Electric Fields
Previous Article in Special Issue
Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction

Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
*
Author to whom correspondence should be addressed.
Molecules 2020, 25(15), 3372; https://doi.org/10.3390/molecules25153372
Submission received: 24 April 2020 / Revised: 20 July 2020 / Accepted: 24 July 2020 / Published: 24 July 2020
(This article belongs to the Special Issue AI in Drug Design)

Abstract

The use of virtual drug screening can be beneficial to research teams, enabling them to narrow down potentially useful compounds for further study. A variety of virtual screening methods have been developed, typically with machine learning classifiers at the center of their design. In the present study, we created a virtual screener for protein kinase inhibitors. Experimental compound–target interaction data were obtained from the IDG-DREAM Drug-Kinase Binding Prediction Challenge. These data were converted and fed as inputs into two multi-input recurrent neural networks (RNNs). The first network utilized data encoded in one-hot representation, while the other incorporated embedding layers. The models were developed in Python, and were designed to output the IC50 of the target compounds. The performance of the models was assessed primarily through analysis of the Q2 values produced from runs of differing sample and epoch size; recorded loss values were also reported and graphed. The performance of the models was limited, though multiple changes are proposed for potential improvement of a multi-input recurrent neural network-based screening tool.
Keywords: artificial intelligence (AI); machine learning (ML); deep learning (DL); recurrent neural network (RNN); virtual drug screening artificial intelligence (AI); machine learning (ML); deep learning (DL); recurrent neural network (RNN); virtual drug screening
Graphical Abstract

Share and Cite

MDPI and ACS Style

Carpenter, K.; Pilozzi, A.; Huang, X. A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction. Molecules 2020, 25, 3372. https://doi.org/10.3390/molecules25153372

AMA Style

Carpenter K, Pilozzi A, Huang X. A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction. Molecules. 2020; 25(15):3372. https://doi.org/10.3390/molecules25153372

Chicago/Turabian Style

Carpenter, Kristy, Alexander Pilozzi, and Xudong Huang. 2020. "A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction" Molecules 25, no. 15: 3372. https://doi.org/10.3390/molecules25153372

APA Style

Carpenter, K., Pilozzi, A., & Huang, X. (2020). A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction. Molecules, 25(15), 3372. https://doi.org/10.3390/molecules25153372

Article Metrics

Back to TopTop